Overall, the aforementioned data revealed a previously undefined role of SENP6 and indicated that inhibiting the activity of SENP6 or its binding with Nrf2 would be a novel and promising therapeutic strategy for ischemic stroke and possibly other neurological disorders characterized by oxidative stress manifestations. Here, NFE2L2 is linked to ischemic stroke.